Using the tumor marker model depicted by Figure 2, this decrease of S100B should reflect a slow reduction of total tumor mass as hypothesized under efficient checkpoint inhibitor therapy by Figure 1, graph C2. The gene discussed is S100B; the disease is neoplasm.